Jeff Landau
About Jeff Landau
Jeff Landau's Current Role
Jeff Landau serves as the Senior Vice President, Head of Strategy and Chief Business Officer. In this role, he oversees strategic initiatives and business operations. His responsibilities include corporate development, corporate strategy, and new product strategy and planning. With over 20 years of experience in the biopharmaceutical industry, he brings a wealth of expertise to his leadership position.
Professional Experience at Catalyst Biosciences
Most recently, Jeff Landau was the Senior Vice President of Corporate Development, Commercial, and New Product Strategy at Catalyst Biosciences, Inc. As a member of the executive management team, he was responsible for key areas such as partnering, license and acquisition, corporate strategy, and pipeline and new product planning. His role also involved alliance and project management.
Previous Roles at Threshold Pharmaceuticals and Onyx Pharmaceuticals
Jeff Landau previously held significant roles in corporate development and global product and pipeline strategy at Threshold Pharmaceuticals and Onyx Pharmaceuticals. At both companies, he took on increasing responsibilities, gaining valuable experience that culminated when Onyx Pharmaceuticals was acquired by Amgen. His work at these companies contributed to his extensive background in the biopharmaceutical sector.
Jeff Landau's Education
Jeff Landau received his M.B.A. from Stanford Graduate School of Business, equipping him with advanced business management skills. He also holds a B.S. with honors in biochemistry/biotechnology from Virginia Polytechnic Institute. This solid educational foundation supports his expertise in corporate development, strategy, and new product planning in the biopharmaceutical industry.